Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106593744 | 10659374 | 4 | F | 2014 | 20160824 | 20141217 | 20160829 | EXP | DE-GILEAD-2014-0127356 | GILEAD | 49.00 | YR | A | M | Y | 100.00000 | KG | 20160829 | MD | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106593744 | 10659374 | 1 | PS | SOFOSBUVIR | SOFOSBUVIR | 1 | Oral | 400 MG, QD | 13600 | MG | Y | 204671 | 400 | MG | TABLET | QD | |||
| 106593744 | 10659374 | 2 | SS | PEGINTERFERON ALFA-2A | PEGINTERFERON ALFA-2A | 1 | Subcutaneous | 180 ?G, Q1WK | 746.341003 | UG | Y | 0 | 180 | UG | /wk | ||||
| 106593744 | 10659374 | 3 | SS | RIBAVIRIN. | RIBAVIRIN | 1 | Oral | 1200 MG, QD | 40800 | MG | Y | 0 | 1200 | MG | QD | ||||
| 106593744 | 10659374 | 4 | C | BISOPROLOL RATIOPHARM | BISOPROLOL | 1 | UNK | 0 | |||||||||||
| 106593744 | 10659374 | 5 | C | ALLOPURINOL. | ALLOPURINOL | 1 | 0 | ||||||||||||
| 106593744 | 10659374 | 6 | C | AMLODIPIN /00972401/ | AMLODIPINE BESYLATE | 1 | 0 | ||||||||||||
| 106593744 | 10659374 | 7 | C | CANDESARTAN | CANDESARTAN | 1 | 0 | ||||||||||||
| 106593744 | 10659374 | 8 | C | TORASEMID | TORSEMIDE | 1 | 0 | ||||||||||||
| 106593744 | 10659374 | 9 | C | DOMINAL /00002701/ | ASPIRIN | 1 | 0 | ||||||||||||
| 106593744 | 10659374 | 10 | C | SUBUTEX | BUPRENORPHINE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 106593744 | 10659374 | 11 | C | CARVEDILOL. | CARVEDILOL | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 106593744 | 10659374 | 1 | Hepatitis C |
| 106593744 | 10659374 | 2 | Hepatitis C |
| 106593744 | 10659374 | 3 | Hepatitis C |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 106593744 | 10659374 | HO |
| 106593744 | 10659374 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 106593744 | 10659374 | Abscess | |
| 106593744 | 10659374 | Anaemia | |
| 106593744 | 10659374 | Appetite disorder | |
| 106593744 | 10659374 | Arthralgia | |
| 106593744 | 10659374 | Cardiovascular disorder | |
| 106593744 | 10659374 | General physical health deterioration | |
| 106593744 | 10659374 | Haematochezia | |
| 106593744 | 10659374 | Headache | |
| 106593744 | 10659374 | Increased tendency to bruise | |
| 106593744 | 10659374 | Local swelling | |
| 106593744 | 10659374 | Pain in jaw | |
| 106593744 | 10659374 | Pancytopenia | |
| 106593744 | 10659374 | Poor dental condition | |
| 106593744 | 10659374 | Presyncope |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 106593744 | 10659374 | 1 | 20140411 | 20140522 | 0 | |
| 106593744 | 10659374 | 2 | 20140411 | 20140522 | 0 | |
| 106593744 | 10659374 | 3 | 20140411 | 20140522 | 0 | |
| 106593744 | 10659374 | 4 | 20061101 | 0 |